Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study

INTRODUCTION: The non-interventional study (NIS) KORALLE evaluated the effectiveness and safety of bevacizumab in patients with metastatic colorectal carcinoma (mCRC) treated with bevacizumab in combination with fluoropyrimidine-based chemotherapy in the first-line setting and beyond first progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Dirk, Eggers, Egbert, Uhlig, Jens, Reichert, Dietmar, Becker, Lars, Thiebach, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677830/
https://www.ncbi.nlm.nih.gov/pubmed/35858533
http://dx.doi.org/10.1159/000525031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677830/
https://www.ncbi.nlm.nih.gov/pubmed/35858533
http://dx.doi.org/10.1159/000525031

Ejemplares similares